BUMA PHARMA
ActiveSummary
BUMA PHARMA has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,507 and a net result of €14,746. Equity is growing by ~57.8% per year across the filed fiscal years. Its solvency ranks better than 78% of 22,078 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Register details
Identification
Legal formPrivate limited company
Founded03-07-2023
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
68110Buying and selling of own real estate
70200Business and other management consultancy
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0803488513
Also
9925:BE0803488513
Registered
07-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 7 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2023
Ground area
2,317 m²
Building footprint
1,211 m²
Volume, LiDAR
4,837 m³
Parcel 11463D0335/00E005, Flanders · tallest building 6.8 m, ±1 floor. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
BUMA PHARMA
since 2023unit no. 2.347.058.520
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11463D0335/00E005 | Flanders | 2,317 m² | 1 · 1,211 m² | 6.8 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.